HK1 and metabolic dysfunction-associated steatotic liver disease: Although the detailed molecular mechanism remains unknown, we tested the effects oflncRP11-675F6.3 and HK1in vivo and found that eitherlncRP11-675F6.3 or HK1 could significantly relieve HFD-induced NAFLD by inhibiting autophagy and promoting VLDL assembly.